Ingredient record · Blood pressure medicine (ARB)
Olmesartan: bans, restrictions and failed batches in India
Last checked 3 November 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Sep 2026
2 entries containing Olmesartan are on India's banned-drugs list, and 1 is banned today. 12 batches of medicines containing Olmesartan failed a government lab test between January 2020 and September 2026, from 11 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
1
Banned combinations in force
1
Other listed orders (stayed, restricted, quashed)
12
Batches failed a lab test
Sep 2026
Latest lab alert
On the banned-drugs list
Olmesartan on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Olmesartan + Hydrochlorothiazide + ChlorthalidoneFixed-dose combination · cardiac | Banned | S.O. 4455(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Olmesartan + Hydrochlorothiazide + ChlorthalidoneFixed-dose combination · cardiac | Quashed | S.O. 787(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Olmesartan Medoxomil | 5 | 4 | Aug 2026 |
| Olmesartan Medoxomil Amlodipine Hydrochlorothiazide | 1 | 1 | Sep 2026 |
| Olmesartan Medoxomil Chlorthalidone Clinidipine | 1 | 1 | Sep 2026 |
| Olmesartan Medoxomil Hydrochlorothiazide | 1 | 1 | Sep 2026 |
| Olmesartan Medoxomil Olmeson | 1 | 1 | Dec 2025 |
| Omitan | 1 | 1 | Apr 2023 |
| Olmesartan Medoxomil Amlodipine | 1 | 1 | Mar 2022 |
| Olmemark | 1 | 1 | Jan 2020 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Olmesartan Medoxomil, chlorthalidone And Clinidipine Tablets | Batch LMT26074Mfg Feb 2026 · Exp Jan 2028 | Alwashank Life Max Cancer LaboratoriesUttarakhand | The Content of Cilnidipine in the Sample is less i.e. 51.80% of Stated Amount) than Schedule V Limit. (Schedule V Limit:- Not less than 90% and Not More than 110% of Stated Amount)Other | FDAL, M. S Chhatrapatri Sambhajinagar, F.D.A Mahrasthra StateState lab | Sep 2026 |
| Olmesartan Medoxomil, Hydrochlorothiazide | Batch GT35462AMfg Jul 2026 · Exp Jun 2028 | J.M. LaboratoriesHimachal Pradesh | The sample does not conforms to the claim with respect to Assay of Olmesartan Medoxomil.Assay | DTL, JaipurState lab | Sep 2026 |
| Olmesartan Medoxomil Amlodipine & Hydrochlorothiazide Tablets | Batch Q15Y005Mfg Dec 2025 · Exp Nov 2027 | MANKIND PHARMA LTD. Doring BlockSikkim | The sample does not conform to declared formula, in respect of content of Olmesartan Medoxomil and Amlodipine.Other | LUCKNOW, Uttar PradeshState lab | Sep 2026 |
| Olmesartan Medoxomil Tablets IP | Batch T250250Mfg May 2025 · Exp Apr 2027 | Medirin Pharmaceuticals Pvt. Ltd. - 408 HSIIDC | The sample does not conform to IP, in respect of Description, Dissolution & Assay.Assay | LUCKNOW LABState lab | Aug 2026 |
| Olmesartan Medoxomil Tablets IP 40 mg OLMESON-40 | Batch T-6585Mfg Jul 2025 · Exp Jul 2027 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample received does not conform to I.P. 2022, I.P. addendum 2024 specification with respect to The test for Dissolution only.Dissolution | CDTL-HyderabadCDSCO lab | Dec 2025 |
| Olmesartan Medoxomil Tablets IP 20mg | Batch GT250287Mfg Feb 2025 · Exp Jan 2027 | Theon Pharmaceuticals LtdHimachal Pradesh | Sample fails the test Dissolution as per IP, as specified in the Laboratory ProtocolDissolution | DTL Thiruvananthapuram,KeralaState lab | Dec 2025 |
| Olmesartan Medoxomil Tablets IP 40 mg | Batch LMT240387Mfg Mar 2024 · Exp Feb 2026 | Life Max Cancer Laboratories | Dissolution of Olmesartan MedoxomilDissolution | RDTL GuwahatiCDSCO lab | Aug 2024 |
| Olmesartan Medoxomil Tablets IP 40 mg | Batch GT22183 1Mfg Oct 2022 · Exp Sep 2024 | Theon Pharmaceuticals LtdHimachal Pradesh | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Jul 2023 |
| Omitan ? 20 (Olmesartan Medoxomil Tablets I.P.) | Batch T-3567Mfg Apr 2022 · Exp Mar 2024 | Jackson Laboratories Pvt. LtdPunjab | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Apr 2023 |
| Olmesartan Medoxomil and Amlodipine Tablets (OLMISAVE AM-40 TABLETS) | Batch CT11211Mfg Dec 2020 · Exp Nov 2022 | Cosmas Pharmacls LtdHimachal Pradesh | AssayAssay | RDTL ChandigarhState lab | Mar 2022 |
| Olmesartan Medoxomil Tablets IP Olmesartan Medoxomil I.P. 40mg | Batch 20S1GTA060Mfg Jun 2020 · Exp May 2022 | Synokem Pharmaceuticals LtdUttarakhand | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Sep 2021 |
| Olmemark-40 (Olmesartan Medoxomil Tablet IP 40 mg) | Batch TPT8689Mfg Jun 2018 · Exp May 2020 | Trugen Pharmaceuticals Pvt. LtdUttarakhand | DissolutionDissolution | CDTL MumbaiCDSCO lab | Jan 2020 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.